More on RXRX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (4.0 Score)

Upcoming Events

- Earnings (8/5/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Recursion Pharmaceuticals (NQ:RXRX)
Delayed: 3.46 -0.08 (2.26%)
Prev. Close $3.54  
Open$3.47 
52 Wk High$ 
52 Wk Low$ 
Day High$3.53 
Day Low$3.38 
P/E N/A  
EPS$ 
Volume12,178,464 

Friends, Peers and Foes (?): DVAX, SDGR, RLYB, BDRX, TPST (more...)

Mar 5, 2026 08:31 AM PacBio adds Recursion co-founder Chris Gibson to board
Mar 5, 2026 08:30 AM PacBio Announces the Appointment of Chris Gibson to the Board of Directors
Mar 4, 2026 04:39 PM Form 4 RECURSION PHARMACEUTICAL For: Mar 03 Filed by: Borgeson Blake
Mar 3, 2026 12:45 PM Form 144 RECURSION PHARMACEUTICAL Filed by: Borgeson Blake
Feb 25, 2026 12:03 PM Recursion Pharmaceuticals (RXRX) PT Lowered to $6 at BofA Securities
Feb 25, 2026 09:39 AM AI Biotech, APAC Expansion, and Balance Sheet Rebuilds Set the Morning Tone
Feb 25, 2026 07:25 AM Recursion Pharmaceuticals, Inc. (RXRX) Tops Q4 EPS by 9c
Feb 25, 2026 06:48 AM Form S-8 RECURSION PHARMACEUTICAL
Feb 25, 2026 06:45 AM Form 424B5 RECURSION PHARMACEUTICAL
Feb 25, 2026 06:35 AM Form 10-K RECURSION PHARMACEUTICAL For: Dec 31
View All Articles

Entities mentioned with RXRX

View All Entities